Genotox Laboratories

Genotox Laboratories was a U.S.-based clinical laboratory focused on toxicology and pharmacogenetic testing services rather than therapeutics development. The company marketed DNA-verified urine drug testing and pharmacogenetic testing products for medication and sobriety monitoring, with applications in pain management, addiction, psychiatry, and primary care. Its flagship branded offerings included NextGenUDT and ToxProtect. Although the company website has described a CLIA-certified, high-complexity laboratory in Austin, Texas, public records indicate the business entered Chapter 7 bankruptcy in April 2024. As a result, Genotox appears to have been a healthcare diagnostics/services company rather than a biotech drug developer and does not appear to have a traditional therapeutic pipeline.